MDx play Curetis adds to B round

Molecular diagnostics company Curetis AG (Holzgerlingen, Germany) raised EUR 14.5 million ($18 million) in an extension of its series B round. New investors Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) and LSP Health Economics Fund (LSP-HEF) invested a total of EUR 7 million ($8.7 million), while all of Curetis' existing investors provided the balance.

Curetis raised EUR 12.5 million ($16.3 million) in the round last year (see BioCentury Extra, April 23, 2013). ...